Home | Sitemap | Search | Contact A- A A+
   
 
    Public Member Support us  
 

IBCSG 29-03 / BIG 3-98 

A survey to assess the attitude of patients aged less than 35 years, with early breast cancer, towards the risk of loss of fertility related to adjuvant therapies.

DESIGN

Design Trial 29-03

Study Chairs
Dr. Olivia Pagani - Mendrisio, Switzerland
Dr. Laura Orlando - Milano, Italy

Trial Coordinator
Susanne Roux
IBCSG Coordinating Center, Bern, Switzerland
Phone: +41 31 389 93 91
Fax: +41 31 389 93 92

Date of Activation
October 3, 2003

Date of Closure
January 28, 2008

Targeted Accrual
385 patients

Final Accrual
394 patients (IBCSG 42)


News

18.12.2014:
New publications are available 

11.12.2014:
San Antonio Breast Cancer Symposium 2014: IBCSG Presents SOFT Results.

10.12.2014:
IBCSG and Merck Announce Opening of International PANACEA Study of Patients with HER2+ Breast

All News

 
  Print